SCHEMBL9764977

SCHEMBL9764977

CC(=O)n1c2ccccc2c2cc(C(C)N(O)C(N)=O)ccc21

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
ALOX5 P09917 11/20 0.51
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764930 0.87 ALOX5 (0.51) ALOX5LMNA
SCHEMBL10559855 0.86 ALOX5 (0.52) ALOX5
SCHEMBL9764877 0.74 ALOX5 (0.56) ALOX5
SCHEMBL2391967 0.73 ALOX5 (0.51) ALOX5LMNA
SCHEMBL10559599 0.73 ALOX5 (0.59) ALOX5LMNA
SCHEMBL10563819 0.73 ALOX5 (0.55) ALOX5
SCHEMBL29787117 0.72 POLB (1.00) POLBLMNA
SCHEMBL153365 0.72 POLB (1.00) POLBLMNA
SCHEMBL29771433 0.72 POLB (1.00) POLBLMNA
SCHEMBL9764967 0.72 POLB (0.51) POLBALOX5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422079-A4 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE 1991-08-21 EP disclosed
EP-0422079-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1991-04-17 EP disclosed
WO-1989012636-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1989-12-28 WO disclosed
EP-0346939-A1 Tricyclic lipoxygenase inhibiting compounds ABBOTT LABORATORIES (US) 1989-12-20 EP disclosed
US-4822811-A Carbazole lipoxygenase inhibiting compounds, compositions and use ABBOTT LABORATORIES (US) 1989-04-18 US disclosed